TD Cowen Maintains Hold on Hims & Hers Health, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Positive 58.8%

Neg 0% Neu 0% Pos 58.8%

TD Cowen analyst Jonna Kim maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from $25 to $30.